Home / Inspections / 1098819

FDA Inspection 1098819 — Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. — FEI 3005209462

The FDA completed an inspection of Supernus Pharmaceuticals, Inc. on July 10, 2019 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1280332 (NAI Thu Jul 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1109126 (NAI Thu Oct 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010922 (VAI Fri Feb 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 915034 (NAI Mon Feb 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888135 (NAI Thu Jun 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources